Integer Holdings ( (ITGR) ) has shared an update.
On April 11, 2025, Integer Holdings Corporation announced that the recent tariffs are expected to have an immaterial impact on its 2025 financial results, estimating an effect of $1 to $5 million on full-year adjusted operating income. The company has implemented and planned mitigation actions to address these tariffs, which were announced by the U.S. on April 2, 2025. This announcement reflects the company’s strategic positioning to manage external economic challenges and maintain its operational stability.
Spark’s Take on ITGR Stock
According to Spark, TipRanks’ AI Analyst, ITGR is a Outperform.
Integer Holdings shows solid financial performance, driven by strong revenue and cash flow growth, and a positive earnings call sentiment. However, the stock’s technical indicators suggest caution due to bearish trends, and its high P/E ratio indicates overvaluation. Strategic acquisitions and positive guidance for 2025 contribute positively, but potential tariff impacts and market exit risks present challenges.
To see Spark’s full report on ITGR stock, click here.
More about Integer Holdings
Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations, serving markets such as cardiac rhythm management, neuromodulation, and cardio and vascular. It partners with medical device companies and OEMs to provide innovative, high-quality products and solutions, with brands including Greatbatch Medical and Lake Region Medical.
YTD Price Performance: -13.88%
Average Trading Volume: 482,102
Technical Sentiment Signal: Hold
Current Market Cap: $4.06B
See more data about ITGR stock on TipRanks’ Stock Analysis page.